tiprankstipranks
Trending News
More News >
Lexicon Pharmaceuticals (LXRX)
:LXRX
US Market

Lexicon Pharmaceuticals (LXRX) Income Statement

Compare
1,737 Followers

Lexicon Pharmaceuticals Income Statement

Last quarter (Q3 2025), Lexicon Pharmaceuticals's total revenue was $14.18M, an increase of 710.40% from the same quarter last year. In Q3, Lexicon Pharmaceuticals's net income was $-12.77M. See Lexicon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 31.08M$ 1.20M$ 139.00K$ 298.00K$ 24.00M
Gross Profit
$ 30.46M$ -57.77M$ -52.38M$ -54.75M$ 22.07M
Operating Expenses
$ 227.58M$ 113.98M$ 48.38M$ 32.34M$ 69.87M
Depreciation and Amortization
$ 534.00K$ 554.00K$ 427.00K$ 292.00K$ 2.93M
EBITDA
$ -184.29M$ -169.76M$ -100.03M$ -86.80M$ -41.10M
Operating Income
$ -197.12M$ -171.75M$ -100.76M$ -87.09M$ -47.80M
Other Income/Expenses
$ -3.29M$ -5.37M$ -1.18M$ -668.00K$ -10.77M
Pretax Income
$ -200.40M$ -177.12M$ -101.94M$ -87.76M$ -58.57M
Net Income
$ -200.40M$ -177.12M$ -101.94M$ -87.76M$ -58.57M
Per Share Metrics
Basic EPS
$ -0.63$ -0.80$ -0.62$ -0.61$ -0.63
Diluted EPS
$ -0.63$ -0.80$ -0.62$ -0.61$ -0.63
Weighted Average Shares Outstanding
320.03M 221.13M 165.73M 145.65M 110.84M
Weighted Average Shares Outstanding (Diluted)
320.03M 221.13M 165.73M 145.65M 110.84M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History